Valeda red light therapy
Valeda® light therapy for dry macular degeneration
Valeda is a non-invasive, in-office light therapy for dry age-related macular degeneration. It is the first FDA-authorized treatment for vision loss in dry AMD.
For patients
For providers
A new option for dry AMD — before vision is lost
For years, patients with dry AMD were told there was little to do but watch and wait. Valeda is a gentle, non-invasive light treatment that may help improve and preserve vision in early and intermediate dry AMD — now available at Retina Group of New York.
What it’s like
Non-invasive and painless — no needles, no dilation, no eye speculum.
Quick — each session takes only a few minutes.
A short series, repeated — in the clinical study, nine short sessions over three to five weeks, repeated a few times per year.
Is Valeda right for me?
Valeda is intended for patients with early to intermediate dry AMD — not wet AMD. The best way to know is a consultation with our retina specialists.
Ask whether this treatment is right for you
Dr. Maisel will evaluate your retina with advanced imaging and explain every option.